Unknown

Dataset Information

0

Mechanism of Enhanced MerTK-Dependent Macrophage Efferocytosis by Extracellular Vesicles.


ABSTRACT: OBJECTIVE:Extracellular vesicles secreted by cardiosphere-derived cells (CDCev) polarize macrophages toward a distinctive phenotype with enhanced phagocytic capacity (MCDCev). These changes underlie cardioprotection by CDCev and by the parent CDCs, notably attenuating the no-reflow phenomenon following myocardial infarction, but the mechanisms are unclear. Here, we tested the hypothesis that MCDCev are especially effective at scavenging debris from dying cells (ie, efferocytosis) to attenuate irreversible damage post-myocardial infarction. Approach and Results: In vitro efferocytosis assays with bone marrow-derived macrophages, and in vivo transgenic rodent models of myocardial infarction, demonstrate enhanced apoptotic cell clearance with MCDCev. CDCev exposure induces sustained MerTK expression in MCDCev through extracellular vesicle transfer of microRNA-26a (via suppression of Adam17); the cardioprotective response is lost in animals deficient in MerTK. Single-cell RNA-sequencing revealed phagocytic pathway activation in MCDCev, with increased expression of complement factor C1qa, a phagocytosis facilitator. CONCLUSIONS:Together, these data demonstrate that extracellular vesicle modulation of MerTK and C1qa expression leads to enhanced macrophage efferocytosis and cardioprotection.

SUBMITTER: de Couto G 

PROVIDER: S-EPMC6760997 | biostudies-literature | 2019 Oct

REPOSITORIES: biostudies-literature

altmetric image

Publications

Mechanism of Enhanced MerTK-Dependent Macrophage Efferocytosis by Extracellular Vesicles.

de Couto Geoffrey G   Jaghatspanyan Ervin E   DeBerge Matthew M   Liu Weixin W   Luther Kristin K   Wang Yizhou Y   Tang Jie J   Thorp Edward B EB   Marbán Eduardo E  

Arteriosclerosis, thrombosis, and vascular biology 20190822 10


<h4>Objective</h4>Extracellular vesicles secreted by cardiosphere-derived cells (CDC<sub>ev</sub>) polarize macrophages toward a distinctive phenotype with enhanced phagocytic capacity (M<sub>CDCev</sub>). These changes underlie cardioprotection by CDC<sub>ev</sub> and by the parent CDCs, notably attenuating the no-reflow phenomenon following myocardial infarction, but the mechanisms are unclear. Here, we tested the hypothesis that M<sub>CDCev</sub> are especially effective at scavenging debris  ...[more]

Similar Datasets

| S-EPMC8149813 | biostudies-literature
| S-EPMC5531255 | biostudies-literature
| S-EPMC7408610 | biostudies-literature
| S-EPMC4761285 | biostudies-literature
| S-EPMC8577498 | biostudies-literature
| S-EPMC2849392 | biostudies-literature
| S-EPMC8107826 | biostudies-literature
| S-EPMC3409281 | biostudies-literature
| S-EPMC4047901 | biostudies-other
| S-EPMC8303898 | biostudies-literature